Literature DB >> 21723628

Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes.

Vikas Bhalla, Vasiliki V Georgiopoulou, Ali A Azeem, Catherine N Marti, Robert T Cole, Sonjoy R Laskar, Christine De Staercke, W Craig Hooper, Andrew L Smith, Andreas P Kalogeropoulos, Javed Butler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21723628      PMCID： PMC3988491          DOI： 10.1016/j.ijcard.2011.06.048

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  26 in total

1.  The 6-minute walk test and prognosis in chronic heart failure--the available evidence.

Authors:  R Sharma; S D Anker
Journal:  Eur Heart J       Date:  2001-03       Impact factor: 29.983

2.  Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation.

Authors:  P Rouet-Benzineb; J M Buhler; P Dreyfus; A Delcourt; R Dorent; J Perennec; B Crozatier; A Harf; C Lafuma
Journal:  Eur J Heart Fail       Date:  1999-12       Impact factor: 15.534

Review 3.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

4.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2009-12-17       Impact factor: 29.690

Review 5.  Matrix metalloproteinases: regulation and dysregulation in the failing heart.

Authors:  Francis G Spinale
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

6.  MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.

Authors:  H Li; H Simon; T M Bocan; J T Peterson
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

7.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

8.  Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.

Authors:  Gregory L Brower; Scott P Levick; Joseph S Janicki
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-02-16       Impact factor: 4.733

9.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

Authors:  C P Green; C B Porter; D R Bresnahan; J A Spertus
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

10.  Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.

Authors:  A Jordán; V Roldán; M García; J Monmeneu; F G de Burgos; G Y H Lip; F Marín
Journal:  J Intern Med       Date:  2007-09       Impact factor: 8.989
View more
  3 in total

Review 1.  Clinical adoption of prognostic biomarkers: the case for heart failure.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Javed Butler
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

Review 2.  Extracellular matrix-mediated cellular communication in the heart.

Authors:  Iñigo Valiente-Alandi; Allison E Schafer; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2016-01-14       Impact factor: 5.000

3.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.